[
    "{\"step_by_step_thinking\": \"Saracatinib is a drug that inhibits Src, a non-receptor tyrosine kinase implicated in tumor progression and metastasis. The documents provided indicate that saracatinib has been used in various studies to suppress invasion and metastasis of different types of cancer, including head and neck squamous cell carcinoma, breast cancer, and hepatocellular carcinoma. Therefore, saracatinib does not promote oncogenesis, but rather, it is used as a treatment to inhibit cancer progression.\", \"answer_choice\": \"B. no\"}"
]